These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 16449211)

  • 1. Atorvastatin reduces the expression of COX-2 mRNA in peripheral blood monocytes from patients with acute myocardial infarction and modulates the early inflammatory response.
    Deng P; Zhao SP; Dai HY; Guan XS; Huang HG
    Clin Chem; 2006 Feb; 52(2):300-3. PubMed ID: 16449211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Atorvastatin reduces the expression of COX-2 mRNA in peripheral blood monocytes in patients with acute myocardial infarction and modulates the early inflammatory response].
    Deng P; Zhao SP; Wu J; Hong SC; Wu ZH; Zhou HN; Nie S
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Nov; 33(11):1018-22. PubMed ID: 16563251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atorvastatin reduces plasma MCP-1 in patients with acute coronary syndrome.
    Xu ZM; Zhao SP; Li QZ; Nie S; Zhou HN
    Clin Chim Acta; 2003 Dec; 338(1-2):17-24. PubMed ID: 14637261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Administration of a loading dose of atorvastatin before percutaneous coronary intervention prevents inflammation and reduces myocardial injury in STEMI patients: a randomized clinical study.
    Liu HL; Yang Y; Yang SL; Luo JP; Li H; Jing LM; Shen ZQ
    Clin Ther; 2013 Mar; 35(3):261-72. PubMed ID: 23410871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydroxymethylglutaryl coenzyme a reductase inhibitors down-regulate chemokines and chemokine receptors in patients with coronary artery disease.
    Waehre T; Damås JK; Gullestad L; Holm AM; Pedersen TR; Arnesen KE; Torsvik H; Frøland SS; Semb AG; Aukrust P
    J Am Coll Cardiol; 2003 May; 41(9):1460-7. PubMed ID: 12742282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effects of 10-mg versus 80-mg Atorvastatin on high-sensitivity C-reactive protein in patients with stable coronary artery disease: results of the CAP (Comparative Atorvastatin Pleiotropic effects) study.
    Bonnet J; McPherson R; Tedgui A; Simoneau D; Nozza A; Martineau P; Davignon J;
    Clin Ther; 2008 Dec; 30(12):2298-313. PubMed ID: 19167589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose atorvastatin reloading before percutaneous coronary intervention increased circulating endothelial progenitor cells and reduced inflammatory cytokine expression during the perioperative period.
    Ye H; He F; Fei X; Lou Y; Wang S; Yang R; Hu Y; Chen X
    J Cardiovasc Pharmacol Ther; 2014 May; 19(3):290-5. PubMed ID: 24346155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of atorvastatin on platelet thromboxane A(2) synthesis in aspirin-treated patients with acute myocardial infarction.
    Santos MT; Fuset MP; Ruano M; Moscardó A; Valles J
    Am J Cardiol; 2009 Dec; 104(12):1618-23. PubMed ID: 19962464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL study.
    Kinlay S; Schwartz GG; Olsson AG; Rifai N; Leslie SJ; Sasiela WJ; Szarek M; Libby P; Ganz P;
    Circulation; 2003 Sep; 108(13):1560-6. PubMed ID: 12975259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effects of atorvastatin on C-reactive protein induced Toll-like receptor 4 expression on CD14+ monocyte].
    Peng L; Luo YT; Liu JL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Jul; 39(7):664-9. PubMed ID: 22088250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atorvastatin increases plasma soluble Fms-like tyrosine kinase-1 and decreases vascular endothelial growth factor and placental growth factor in association with improvement of ventricular function in acute myocardial infarction.
    Kodama Y; Kitta Y; Nakamura T; Takano H; Umetani K; Fujioka D; Saito Y; Kawabata K; Obata JE; Mende A; Kobayashi T; Kugiyama K
    J Am Coll Cardiol; 2006 Jul; 48(1):43-50. PubMed ID: 16814647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atorvastatin restores the balance between pro-inflammatory and anti-inflammatory mediators in rats with acute myocardial infarction.
    Tawfik MK; Ghattas MH; Abo-Elmatty DM; Abdel-Aziz NA
    Eur Rev Med Pharmacol Sci; 2010 Jun; 14(6):499-506. PubMed ID: 20712256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atorvastatin treatment improves the effects of mesenchymal stem cell transplantation on acute myocardial infarction: the role of the RhoA/ROCK/ERK pathway.
    Zhang Q; Wang H; Yang YJ; Dong QT; Wang TJ; Qian HY; Li N; Wang XM; Jin C
    Int J Cardiol; 2014 Oct; 176(3):670-9. PubMed ID: 25139321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intensive treatment with atorvastatin reduces inflammation in mononuclear cells and human atherosclerotic lesions in one month.
    Martín-Ventura JL; Blanco-Colio LM; Gómez-Hernández A; Muñoz-García B; Vega M; Serrano J; Ortega L; Hernández G; Tuñón J; Egido J
    Stroke; 2005 Aug; 36(8):1796-800. PubMed ID: 16020773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of atorvastatin on plasma hypersensitive C-reactive protein and interleukin-6 in patients with acute cerebral infarction].
    Zhao SP; Wu J; Tan LM; Hu ZP; Xiao ZJ; Nie S; Zhou HN; Jiang B
    Zhonghua Yi Xue Za Zhi; 2005 Oct; 85(40):2841-5. PubMed ID: 16324343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of cardiovascular events in statin-treated stable coronary patients by lipid and nonlipid biomarkers.
    Arsenault BJ; Barter P; DeMicco DA; Bao W; Preston GM; LaRosa JC; Grundy SM; Deedwania P; Greten H; Wenger NK; Shepherd J; Waters DD; Kastelein JJ;
    J Am Coll Cardiol; 2011 Jan; 57(1):63-9. PubMed ID: 21185503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of atorvastatin on CYP3A4 and CYP3A5 mRNA expression in mononuclear cells and CYP3A activity in hypercholeresterolemic patients.
    Willrich MA; Rodrigues AC; Cerda A; Genvigir FD; Arazi SS; Dorea EL; Bernik MM; Bertolami MC; Faludi A; Largura A; Baudhuin LM; Bryant SC; Hirata MH; Hirata RD
    Clin Chim Acta; 2013 Jun; 421():157-63. PubMed ID: 23501331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Association between high sensitivity C-reactive protein and contrast induced acute kidney injury in patients with acute coronary syndrome undergoing percutaneous coronary intervention: impact of atorvastatin].
    Su JZ; Xue Y; Cai WQ; Huang QY; Chai DJ; Chen GL; Wang FB; Chen XP; Zhang DS
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Sep; 39(9):807-11. PubMed ID: 22321227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atorvastatin improves microenvironment to enhance the beneficial effects of BMSCs therapy in a rabbit model of acute myocardial infarction.
    Qu Z; Xu H; Tian Y; Jiang X
    Cell Physiol Biochem; 2013; 32(2):380-9. PubMed ID: 23988469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of single-dose atorvastatin on interleukin-6, interferon gamma, and myocardial no-reflow in a rabbit model of acute myocardial infarction and reperfusion.
    Zhao XJ; Liu XL; He GX; Xu HP
    Braz J Med Biol Res; 2014 Feb; 47(3):245-51. PubMed ID: 24554037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.